B Sonfo, C A Thiam, A Kéita, Y Camara, A Diarra, M Sako, M Touré, M Konaté, I Sangaré, H O Ba, M Diakité, B Dembélé, H Camara, S Daffé, D Fofana, S Coulibaly, I Menta
Introduction: Venous thromboembolic disease (MTEV) includes: deep venous thrombosis (DVT) and pulmonary embolism (PE). This work was initiated to identify the female particularities if they exist.
Materials and method: This was a retrospective, descriptive study conductedin the cardiology department of the Kati university hospital over a period from January 01, 2014 to December 31, 2021. Patients hospitalized during the period for venousthromboembolic disease were included. The variables studied were demographic social data, risk factors, clinical and para-clinical parameters, therapeutic and evolutionary aspects.
Results: In total we recorded 68 cases of MTEV of which 40 (58.8%) women. There were 12 (30%) cases of deep vein thrombosis, 25 (62.5%) cases of pulmonary embolism and their association in 3 (7.5%) cases. The majority (82.5%) of patients were housewives. Thepostpartum accounted for 10% of cases. The clinical probability according to the Wells score was high in 93% of deep vein thrombosis, intermediate for cases of pulmonary embolism with 50%. Angio-CT showed that pulmonary embolism was bilateral in 80% of cases. Heparin and anti-vitamin K were the most commonly used. Mortality was 7.5%.
Conclusion: women are more victims of venous thromboembolic diseases than men. Postpartum is a special situation for women. Recurrences are not uncommon.
{"title":"[Venous Thromboembolic Disease In Women In The Cardiology Department Of The Kati University Hospital].","authors":"B Sonfo, C A Thiam, A Kéita, Y Camara, A Diarra, M Sako, M Touré, M Konaté, I Sangaré, H O Ba, M Diakité, B Dembélé, H Camara, S Daffé, D Fofana, S Coulibaly, I Menta","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Venous thromboembolic disease (MTEV) includes: deep venous thrombosis (DVT) and pulmonary embolism (PE). This work was initiated to identify the female particularities if they exist.</p><p><strong>Materials and method: </strong>This was a retrospective, descriptive study conductedin the cardiology department of the Kati university hospital over a period from January 01, 2014 to December 31, 2021. Patients hospitalized during the period for venousthromboembolic disease were included. The variables studied were demographic social data, risk factors, clinical and para-clinical parameters, therapeutic and evolutionary aspects.</p><p><strong>Results: </strong>In total we recorded 68 cases of MTEV of which 40 (58.8%) women. There were 12 (30%) cases of deep vein thrombosis, 25 (62.5%) cases of pulmonary embolism and their association in 3 (7.5%) cases. The majority (82.5%) of patients were housewives. Thepostpartum accounted for 10% of cases. The clinical probability according to the Wells score was high in 93% of deep vein thrombosis, intermediate for cases of pulmonary embolism with 50%. Angio-CT showed that pulmonary embolism was bilateral in 80% of cases. Heparin and anti-vitamin K were the most commonly used. Mortality was 7.5%.</p><p><strong>Conclusion: </strong>women are more victims of venous thromboembolic diseases than men. Postpartum is a special situation for women. Recurrences are not uncommon.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 1","pages":"30-33"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Kodio, I Téguété, S Z Dao, A Sissoko, A Bocoum, S Fané, T Théra, Y Traoré, A Togo, N Mounkoro
Breast cancer is the leading cancer in women worldwide. A better understanding of this pathology by women can contribute to significantly reducing its morbidity and mortality.
Aim: It was to evaluate women's knowledge about breast cancer in the obstetrics and gynecology department of the district hospital of commune II of Bamako.
Patients and methods: We carried out a descriptive and analytical cross-sectional study with prospective collection of data from July 1 to August 31, 2021. It concerned women admitted to gynecological consultation without notion of emergency, who agreed to participate in this study.
Results: In 2 months, 390 women agreed to participate in this study, of which almost half of the women (45.1%) had no knowledge of the risk factors, clinical signs and means of screening for breast cancer. breast. Women's knowledge of breast cancer was influenced by age, education level, profession, religion and marital status (p<0.001).
Conclusion: Breast cancer remains poorly understood by women. Intensifying awareness campaigns can help increase women's understanding of this scourge.
{"title":"[Breast Cancer: Evaluation Of Women's Knowledge In A Second Level Hospital In Bamako, Mali].","authors":"A Kodio, I Téguété, S Z Dao, A Sissoko, A Bocoum, S Fané, T Théra, Y Traoré, A Togo, N Mounkoro","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Breast cancer is the leading cancer in women worldwide. A better understanding of this pathology by women can contribute to significantly reducing its morbidity and mortality.</p><p><strong>Aim: </strong>It was to evaluate women's knowledge about breast cancer in the obstetrics and gynecology department of the district hospital of commune II of Bamako.</p><p><strong>Patients and methods: </strong>We carried out a descriptive and analytical cross-sectional study with prospective collection of data from July 1 to August 31, 2021. It concerned women admitted to gynecological consultation without notion of emergency, who agreed to participate in this study.</p><p><strong>Results: </strong>In 2 months, 390 women agreed to participate in this study, of which almost half of the women (45.1%) had no knowledge of the risk factors, clinical signs and means of screening for breast cancer. breast. Women's knowledge of breast cancer was influenced by age, education level, profession, religion and marital status (p<0.001).</p><p><strong>Conclusion: </strong>Breast cancer remains poorly understood by women. Intensifying awareness campaigns can help increase women's understanding of this scourge.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 2","pages":"40-43"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The aim of this study was to investigate adverse events related to the administration of Covishield vaccine from the AstraZeneca laboratory in volunteers vaccinated at the Dermatology Hospital of Bamako.
Methodology: This was a Phase IV clinical trial involving volunteers vaccinated at the Dermatology Hospital of Bamako from April to June 2021. Scientific and ethical aspects were reviewed and addressed. The proposal for this study was approved by the scientific committee of the Hôpital de Dermatologie de Bamako.
Results: A total of 1099 volunteers were included in the study. The median age of participants was 48 years (18-93 years) with a sex ratio of 1.81 (708/391). In all 90.2% of the 1219 adverse events were injection-site pain. Other adverse events were headache, tiredness, and muscle pain, with 3.2% (39/1219), 2.4% (29/1219) and 1.8% (22/1219) respectively. Only one case of diarrhea was reported, 0.08% (1/1219).
Conclusion: Adverse events to this vaccine were mostly moderate and temporary but vary according to the population vaccinated individuals.
{"title":"[Post-Vaccination Adverse Events Related To The Administration Of The Covishield® Coronavirus Vaccine In Vaccinated Volunteers At The Bamako Dermatology Hospital From April To June 2021].","authors":"Oumar Coulibaly, Yaya Ibrahim Coulibaly, Mamadou Kodio, Mamadou Karim Touré, Abdoulaye Mamadou Traore, Mahamoud Mahamadou Koureichi, Kaman Dembélé, Mamadou Mady Keita, Oumar Traore, Korotoumou Traore, Kadiatou Diallo, Moussa Sangare, Diadje Tanapo, Abdoul Fatao Diabaté, Adama Aguissa Dicko, Claude Akakpo, Ousmane Faye","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate adverse events related to the administration of Covishield vaccine from the AstraZeneca laboratory in volunteers vaccinated at the Dermatology Hospital of Bamako.</p><p><strong>Methodology: </strong>This was a Phase IV clinical trial involving volunteers vaccinated at the Dermatology Hospital of Bamako from April to June 2021. Scientific and ethical aspects were reviewed and addressed. The proposal for this study was approved by the scientific committee of the Hôpital de Dermatologie de Bamako.</p><p><strong>Results: </strong>A total of 1099 volunteers were included in the study. The median age of participants was 48 years (18-93 years) with a sex ratio of 1.81 (708/391). In all 90.2% of the 1219 adverse events were injection-site pain. Other adverse events were headache, tiredness, and muscle pain, with 3.2% (39/1219), 2.4% (29/1219) and 1.8% (22/1219) respectively. Only one case of diarrhea was reported, 0.08% (1/1219).</p><p><strong>Conclusion: </strong>Adverse events to this vaccine were mostly moderate and temporary but vary according to the population vaccinated individuals.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 3","pages":"45-51"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Y Togo, B Bengaly, M Sima, D Ouattara, S Kanté, O I Touré, M Dicko, B T Dembélé, B Sanogo, S Kanté, S Koita, I Téguété, Y Traoré, N Mounkoro, I K Guindo, I Traoré, D Traoré, N Ongoiba
Gigantomastia is a rare benign mastopathy of unknown aetiology. It usually occurs in women during puberty or during pregnancy. It is characterized by excessive breast growth, which is psychologically and physically disabling. It is a pathology little studied because of its rarity. In order to describe the epidemiological, clinical, diagnostic and therapeutic aspects, we report the case of four young women. The study was longitudinal over a period of 3 months. We collected data for 6 years from October 1, 2016, to October 31, 2021, at the surgery department B of the "Centre Hospitalier Universitaire du Point G". All patients who consulted for gigantomastia were included. At the end of our study, we found three cases of juvenile gigantomastia and one case of prepubertal gigantomastia. The couple mammography ultrasound performed in two patients, adenofibroma was associated with breast hypertrophy in one patient. The treatment was essentially surgical in our study. Reduction mammoplasty according to the technique of Mc Kissock and modified Mc Kissock was used. We did not note any complication such as nipple-areolar necrosis. All our patients were satisfied with the result.
巨乳症是一种罕见的良性乳腺疾病,病因不明。它通常发生在青春期或妊娠期的女性身上。其特点是乳房过度增大,会造成心理和生理上的障碍。由于其罕见性,对这种病症的研究很少。为了描述流行病学、临床、诊断和治疗方面的情况,我们报告了四名年轻女性的病例。这项研究是一项为期 3 个月的纵向研究。从2016年10月1日至2021年10月31日,我们在 "Centre Hospitalier Universitaire du Point G "医院外科B部收集了6年的数据。所有因巨人症就诊的患者均被纳入其中。研究结束时,我们发现了三例幼年巨人症和一例青春期前巨人症。有两名患者接受了夫妇乳腺超声波检查,一名患者的腺纤维瘤与乳房肥大有关。在我们的研究中,治疗方法主要是外科手术。根据麦基索克(Mc Kissock)和改良麦基索克(Mc Kissock)技术进行了乳房缩小整形术。我们没有发现乳头乳晕坏死等并发症。所有患者都对手术效果感到满意。
{"title":"[Epidemio-Clinical And Therapeutic Aspects Of Gigantomastia At Point G University Hospital].","authors":"A Y Togo, B Bengaly, M Sima, D Ouattara, S Kanté, O I Touré, M Dicko, B T Dembélé, B Sanogo, S Kanté, S Koita, I Téguété, Y Traoré, N Mounkoro, I K Guindo, I Traoré, D Traoré, N Ongoiba","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gigantomastia is a rare benign mastopathy of unknown aetiology. It usually occurs in women during puberty or during pregnancy. It is characterized by excessive breast growth, which is psychologically and physically disabling. It is a pathology little studied because of its rarity. In order to describe the epidemiological, clinical, diagnostic and therapeutic aspects, we report the case of four young women. The study was longitudinal over a period of 3 months. We collected data for 6 years from October 1, 2016, to October 31, 2021, at the surgery department B of the \"Centre Hospitalier Universitaire du Point G\". All patients who consulted for gigantomastia were included. At the end of our study, we found three cases of juvenile gigantomastia and one case of prepubertal gigantomastia. The couple mammography ultrasound performed in two patients, adenofibroma was associated with breast hypertrophy in one patient. The treatment was essentially surgical in our study. Reduction mammoplasty according to the technique of Mc Kissock and modified Mc Kissock was used. We did not note any complication such as nipple-areolar necrosis. All our patients were satisfied with the result.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 2","pages":"68-72"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I Téguété, A Sissoko, F M Sidibé, F K Tounkara, D Kasse, S Doumbia, F Sidibé, N Mounkoro
Background: Few studies have been conducted on breast cancer despite its high burden in our context. Therefore, this study aimed to: (1) specify the sociodemographic and clinical characteristics of breast cancer; and (2) determine the factors associated with breast cancer survival at Gabriel Touré University Hospital (CHU).
Methods: This was a retrospective cohort study conducted at CHU Gabriel Touré between January 1st2018 and 31st, December 2022. Histologically confirmed cases of breast cancer were included and divided into three anatomoclinical groups (non-T4 tumor [NT4], locally advanced cancer [LAC] and inflammatory breast cancer [IBC]). We used Pearson's Chi-square or Fisher's Exact tests to compare proportions. The frequency distributions using density plots were constructed for the three breast types. They were compared using the Kruskal Wallis statistic. Kaplan-Meier curves were estimated for the survival analysis and Cox regression was used to identify factors associated with breast cancer survival. Adjusted hazard ratios (AHRs) and their 95% confidence intervals (95% CIs) were computed.
Results: A total of 255 cases of breast cancer were included in this study. The mean age was 46.9 years old. Whatever the anatomoclinical type, the density plot curve peaked before the age 40. NT4 and LAC were more frequently observed on the right breast, while IBC occurred on the left breast (p < 0.001). Comorbidity rates were comparable between the three groups. The median survival time was 9 months, and the overall 5-year survival rate was < 40%. Infertility history and IBC had a significant influence on survival, with AHRs of 1,63 [1,01 - 2,63] and 1,52 [1,04 - 2,22] respectively.
Conclusion: Breast cancer at Gabriel Touré University Hospital is characterized by an early onset and a poor prognosis, suggesting that particular emphasis should be placed on early diagnosis and the quality of management.
{"title":"[Comparative Profiles Of Breast Cancers According To Tumor Type At The Gabriel Touré University Hospital, Bamako - Mali, Between 2018 And 2022].","authors":"I Téguété, A Sissoko, F M Sidibé, F K Tounkara, D Kasse, S Doumbia, F Sidibé, N Mounkoro","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Few studies have been conducted on breast cancer despite its high burden in our context. Therefore, this study aimed to: (1) specify the sociodemographic and clinical characteristics of breast cancer; and (2) determine the factors associated with breast cancer survival at Gabriel Touré University Hospital (CHU).</p><p><strong>Methods: </strong>This was a retrospective cohort study conducted at CHU Gabriel Touré between January 1<sup>st</sup>2018 and 31<sup>st</sup>, December 2022. Histologically confirmed cases of breast cancer were included and divided into three anatomoclinical groups (non-T4 tumor [NT4], locally advanced cancer [LAC] and inflammatory breast cancer [IBC]). We used Pearson's Chi-square or Fisher's Exact tests to compare proportions. The frequency distributions using density plots were constructed for the three breast types. They were compared using the Kruskal Wallis statistic. Kaplan-Meier curves were estimated for the survival analysis and Cox regression was used to identify factors associated with breast cancer survival. Adjusted hazard ratios (AHRs) and their 95% confidence intervals (95% CIs) were computed.</p><p><strong>Results: </strong>A total of 255 cases of breast cancer were included in this study. The mean age was 46.9 years old. Whatever the anatomoclinical type, the density plot curve peaked before the age 40. NT4 and LAC were more frequently observed on the right breast, while IBC occurred on the left breast (p < 0.001). Comorbidity rates were comparable between the three groups. The median survival time was 9 months, and the overall 5-year survival rate was < 40%. Infertility history and IBC had a significant influence on survival, with AHRs of 1,63 [1,01 - 2,63] and 1,52 [1,04 - 2,22] respectively.</p><p><strong>Conclusion: </strong>Breast cancer at Gabriel Touré University Hospital is characterized by an early onset and a poor prognosis, suggesting that particular emphasis should be placed on early diagnosis and the quality of management.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 2","pages":"14-22"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: To identify the predictive factors and reduce the mortality of COVID-19 in the Tambacounda region.
Materials and methods: An analytical cross-sectional study was conducted on confirmed COVID-19 individuals. Sampling was exhaustive with 303 cases. Data were collected by literature review, secondary data extraction and interviews. A data extraction form and an Epi Info®7.4.2.0 input mask were used. Medians, numbers, proportions were calculated and odds ratios were estimated. Statistical analysis was performed using Epi Info®7.2.4.0, SAS®9.4 and Excel®2019.
Results: Of the confirmed cases, 58 (19.1%) were deceased. The median age was 59 years (43-69 years). The sex ratio (male to female) was 1.6. Factors independently associated with mortality in COVID-19 were diabetes (ORa=9.34, CI95% [2.15-40.63]); hypertension (ORa=6.51, CI95% [1.85-22.93]); acute respiratory distress (ORa=6.22, CI95% [2.89-13.37]); male sex (ORa=6.44, CI95% [2.22-18.65]) and age ≥ 60 years (ORa=2.62, CI95% [1.14-6.02]).
Conclusion: Prevention strategies targeting diabetics, hypertensives, males, and those at least 60 years old would reduce mortality from COVID-19 in the Tambacounda region.
{"title":"[Factors associated with mortality in patients with COVID-19 in the Tambacounda region, Senegal, 2020-2021].","authors":"Samba Thioub, Mathias NDiaye, Ibou Gueye, Kalidou Djibril Sow, Tidiane Gadiaga, Emmanuel Sopoh, Jean Kaboré, Pauline Kiswendsida Yanogo","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aims: </strong>To identify the predictive factors and reduce the mortality of COVID-19 in the Tambacounda region.</p><p><strong>Materials and methods: </strong>An analytical cross-sectional study was conducted on confirmed COVID-19 individuals. Sampling was exhaustive with 303 cases. Data were collected by literature review, secondary data extraction and interviews. A data extraction form and an Epi Info®7.4.2.0 input mask were used. Medians, numbers, proportions were calculated and odds ratios were estimated. Statistical analysis was performed using Epi Info®7.2.4.0, SAS®9.4 and Excel®2019.</p><p><strong>Results: </strong>Of the confirmed cases, 58 (19.1%) were deceased. The median age was 59 years (43-69 years). The sex ratio (male to female) was 1.6. Factors independently associated with mortality in COVID-19 were diabetes (ORa=9.34, CI95% [2.15-40.63]); hypertension (ORa=6.51, CI95% [1.85-22.93]); acute respiratory distress (ORa=6.22, CI95% [2.89-13.37]); male sex (ORa=6.44, CI95% [2.22-18.65]) and age ≥ 60 years (ORa=2.62, CI95% [1.14-6.02]).</p><p><strong>Conclusion: </strong>Prevention strategies targeting diabetics, hypertensives, males, and those at least 60 years old would reduce mortality from COVID-19 in the Tambacounda region.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 3","pages":"14-21"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: The aim of this study was to determine the association between vitamin D deficiency and advanced BC in a Malian women population.
Methods: This is a prospective cross-sectional study, conducted during 4 months, from August 2021 to November 2021. The assays were performed on immunodiagnostic and biochemistry devices in Rodolphe Merieux Laboratory.
Results: We included 77 women diagnosed with advanced breast cancer. The mean age of the study population was 48.51 ± 13.02 years. The mean plasma concentrations of 25(OH)D were 20.65 ± 6.76 ng/ml and 18.89 ± 6.12 ng/ml (p=0.274) in groups III and IV, respectively. Stage III was predominant, comprising 67.5% of the cases, and there were no significant differences between stages III and IV regarding phospho-calcium biological markers. Our results showed a greater deficiency in vitamin D at stage III compared to stage IV, with p=0.782. The logistic regression model demonstrated a significant decrease in the relative risk of advanced breast cancer across the quartiles of vitamin D (p=0.039). There was no association with serum calcium, phosphate, plasma creatinine, and glomerular filtration rate (GFR) (p>0.05).
Conclusions: Our findings show an decrease of the risk of breast cancer about vitamin D levels in our population. These results suggest an association between vitamin D and the risk of advanced breast cancer. Further studies are needed to determine the mechanism of vitamin D deficiency in advanced breast cancer.
目的:本研究旨在确定马里妇女群体中维生素 D 缺乏与晚期 BC 之间的关系:这是一项前瞻性横断面研究,从2021年8月至2021年11月,历时4个月。检测在罗多尔夫-梅里埃实验室(Rodolphe Merieux Laboratory)的免疫诊断和生化设备上进行:研究对象包括77名确诊为晚期乳腺癌的女性。研究对象的平均年龄为(48.51 ± 13.02)岁。血浆中 25(OH)D 的平均浓度在 III 组和 IV 组分别为 20.65 ± 6.76 ng/ml 和 18.89 ± 6.12 ng/ml (p=0.274)。在磷钙生物标志物方面,III 期和 IV 期之间没有明显差异。我们的研究结果表明,与 IV 期相比,III 期更缺乏维生素 D,P=0.782。逻辑回归模型显示,维生素 D 的四分位数越高,晚期乳腺癌的相对风险越低(p=0.039)。与血清钙、磷酸盐、血浆肌酐和肾小球滤过率(GFR)没有关系(P>0.05):我们的研究结果表明,在我国人群中,患乳腺癌的风险随着维生素 D 水平的升高而降低。这些结果表明,维生素 D 与罹患晚期乳腺癌的风险有关。需要进一步研究确定晚期乳腺癌的维生素 D 缺乏机制。
{"title":"[Vitamin D Deficiency In Advanced Breast Cancer Risk In Mali].","authors":"Aboubacar Dit Tietie Bissan, Awo Emmanuela Hilda Amegonou, Fatoumata Matokoma Sidibé, Madani Ly, Nènè Oumou Kesso Barry, Madiné Tall, Lassana Gadi Timbiné, Bourèma Kouriba, Pascal Reynier, Zahra Ouzzif","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aims: </strong>The aim of this study was to determine the association between vitamin D deficiency and advanced BC in a Malian women population.</p><p><strong>Methods: </strong>This is a prospective cross-sectional study, conducted during 4 months, from August 2021 to November 2021. The assays were performed on immunodiagnostic and biochemistry devices in Rodolphe Merieux Laboratory.</p><p><strong>Results: </strong>We included 77 women diagnosed with advanced breast cancer. The mean age of the study population was 48.51 ± 13.02 years. The mean plasma concentrations of 25(OH)D were 20.65 ± 6.76 ng/ml and 18.89 ± 6.12 ng/ml (p=0.274) in groups III and IV, respectively. Stage III was predominant, comprising 67.5% of the cases, and there were no significant differences between stages III and IV regarding phospho-calcium biological markers. Our results showed a greater deficiency in vitamin D at stage III compared to stage IV, with p=0.782. The logistic regression model demonstrated a significant decrease in the relative risk of advanced breast cancer across the quartiles of vitamin D (p=0.039). There was no association with serum calcium, phosphate, plasma creatinine, and glomerular filtration rate (GFR) (p>0.05).</p><p><strong>Conclusions: </strong>Our findings show an decrease of the risk of breast cancer about vitamin D levels in our population. These results suggest an association between vitamin D and the risk of advanced breast cancer. Further studies are needed to determine the mechanism of vitamin D deficiency in advanced breast cancer.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 2","pages":"50-57"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D Kasse, M Traoré, F M Sidibé, F K Tounkara, P Togo, I Téguété
Introduction: Inflammatory breast cancer (IBC) is very rare worldwide. The objectives of the present study were to determine the frequency, to describe the socio-demographic and clinical characteristics according to the type of CIS (primary and secondary), and to establish the prognosis.
Method: We conducted a retrospective cohort study in the Gynecology-Obstetrics unit of CHU Gabriel Touré (2015 - 2021). Data were analyzed using descriptive statistics and the Kaplan Meier method was used to produce survival curves.
Results: We identified 100 cases of IBC among 588 breast cancer cases including 23 cases of primary IBC (3.59%) and 77 cases of secondary IBC (13.1%). The two types of IBC appeared in a relatively younger and peaked between 35 and 40 years old. Contrary to primary IBC, secondary IBC exhibited a second peak between 55 and 60 years old (Wilcoxon rank, test p > 0.05). The time between symptom onset to disease progression was significantly shorter in primary IBC cases versus secondary one (p < 0.001). Overall survival and specific survival according to the type of IBC were less than 40% after 60 months of followed up.
Conclusion: The incidence of IBC was high in our setting but dominated by secondary IBC. Whatever the type of IBC, the prognosis was poor.
{"title":"[Inflammatory Breast Cancers: Epidemiological Aspects At The Gabriel Touré University Hospital In Bamako, Mali].","authors":"D Kasse, M Traoré, F M Sidibé, F K Tounkara, P Togo, I Téguété","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Inflammatory breast cancer (IBC) is very rare worldwide. The objectives of the present study were to determine the frequency, to describe the socio-demographic and clinical characteristics according to the type of CIS (primary and secondary), and to establish the prognosis.</p><p><strong>Method: </strong>We conducted a retrospective cohort study in the Gynecology-Obstetrics unit of CHU Gabriel Touré (2015 - 2021). Data were analyzed using descriptive statistics and the Kaplan Meier method was used to produce survival curves.</p><p><strong>Results: </strong>We identified 100 cases of IBC among 588 breast cancer cases including 23 cases of primary IBC (3.59%) and 77 cases of secondary IBC (13.1%). The two types of IBC appeared in a relatively younger and peaked between 35 and 40 years old. Contrary to primary IBC, secondary IBC exhibited a second peak between 55 and 60 years old (Wilcoxon rank, test p > 0.05). The time between symptom onset to disease progression was significantly shorter in primary IBC cases versus secondary one (p < 0.001). Overall survival and specific survival according to the type of IBC were less than 40% after 60 months of followed up.</p><p><strong>Conclusion: </strong>The incidence of IBC was high in our setting but dominated by secondary IBC. Whatever the type of IBC, the prognosis was poor.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 2","pages":"28-34"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Guindo, S Coulibaly, Yr Koumaré, S Diallo, A K Sacko, A Sangaré, B Dembélé, M Sacko, S Sidibé, M Diakité
Aortic dissection (AD) is a medicosurgical emergency whose diagnosis has been considerably facilitated in recent years by the development of reliable and easily available diagnostic methods such as echocardiography, spiral CT angiography, and even magnetic resonance imaging. The prognosis remains serious, particularly when the ascending aorta is involved (type A AD), therefore immediate surgical treatment can considerably reduce its mortality. The prognosis for dissections of the descending thoracic aorta (type B) is the best; treatment is primarily medical in the absence of complications. We report two cases of unexploited Stanford type A aortic dissection respectively in a 38-year-old patient and a 52-year-old patient, both with a fatal outcome, and two case of type B aortic dissection with a favorable outcome. These observations highlight the need to raise awareness among our populations about cardiovascular emergencies and challenge our health policies in order to improve the technical platform concerning the diagnosis and management of these dissections.
主动脉夹层(AD)是一种内外科急症,近年来,随着超声心动图、螺旋 CT 血管造影、甚至磁共振成像等可靠而简便的诊断方法的发展,主动脉夹层的诊断变得更加容易。其预后仍然很严重,尤其是当升主动脉受累时(A 型 AD),因此立即进行手术治疗可以大大降低死亡率。胸主动脉降支(B 型)的预后最好;在没有并发症的情况下,主要采用药物治疗。我们报告了两例未发现的斯坦福 A 型主动脉夹层病例,患者分别为 38 岁和 52 岁,结果均为死亡,还有两例 B 型主动脉夹层病例,结果良好。这些观察结果突出表明,有必要提高人们对心血管急症的认识,并对我们的卫生政策提出挑战,以改善有关诊断和处理这些夹层的技术平台。
{"title":"[Aortic Dissection In The Cardiology Department Of The Point G University Hospital (Mali): Cardiovascular Emergency About 4 Observations].","authors":"A Guindo, S Coulibaly, Yr Koumaré, S Diallo, A K Sacko, A Sangaré, B Dembélé, M Sacko, S Sidibé, M Diakité","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Aortic dissection (AD) is a medicosurgical emergency whose diagnosis has been considerably facilitated in recent years by the development of reliable and easily available diagnostic methods such as echocardiography, spiral CT angiography, and even magnetic resonance imaging. The prognosis remains serious, particularly when the ascending aorta is involved (type A AD), therefore immediate surgical treatment can considerably reduce its mortality. The prognosis for dissections of the descending thoracic aorta (type B) is the best; treatment is primarily medical in the absence of complications. We report two cases of unexploited Stanford type A aortic dissection respectively in a 38-year-old patient and a 52-year-old patient, both with a fatal outcome, and two case of type B aortic dissection with a favorable outcome. These observations highlight the need to raise awareness among our populations about cardiovascular emergencies and challenge our health policies in order to improve the technical platform concerning the diagnosis and management of these dissections.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 3","pages":"69-74"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K Kéita, A Kassambara, A Touré, A Ba, B S Sidibé, H Koita, F Diakité, S Togolo, A Coulibaly, B Ba
Introduction: Fibroma ossificans are usually well-defined tumours, but are rarely encapsulated. The choice of radical or conservative treatment is a challenge for the maxillofacial surgeon. The aim of this case report was to describe the particularities of the management of a case of ossifying fibroma of the mandible.
Case report: The patient was a 17-year-old housewife with a history of caesarean section. She presented with a mandibular swelling that had been evolving for 6 years, with no other functional signs and no change in general condition. Exobuccal examination revealed a voluminous symphyseal swelling, covered by healthy-looking skin, with a bony consistency and forming part of the mandible. On endobuccal examination, there was a vestibular swelling extending from 36 to 45, covered by healthy-looking mucosa, with the absence of teeth 31, 32, 41, 42 and 43 and mobility of teeth 33 and 34. The hypothesis of a benign tumour of the mandible was raised. A maxillofacial CT scan revealed a heterogeneous image with local areas of hyperdensity and blowing of the external cortex. Treatment consisted of an interrupting mandibular resection via the vestibular approach, followed by transitional reconstruction using a stent graft. Histological examination of the surgical specimen revealed an ossifying fibroma. The outcome was favourable, with no recurrence after approximately 2 years.
Conclusion: Treatment of ossifying fibroids can often be mutilating. It is discussed according to the clinical and radiological characteristics of the lesion.
{"title":"[Giant Ossifiant Fibrome Of The Mandibule In The Adolescent At The National Center D'odonto-Stomatologie Of Bamako].","authors":"K Kéita, A Kassambara, A Touré, A Ba, B S Sidibé, H Koita, F Diakité, S Togolo, A Coulibaly, B Ba","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Fibroma ossificans are usually well-defined tumours, but are rarely encapsulated. The choice of radical or conservative treatment is a challenge for the maxillofacial surgeon. The aim of this case report was to describe the particularities of the management of a case of ossifying fibroma of the mandible.</p><p><strong>Case report: </strong>The patient was a 17-year-old housewife with a history of caesarean section. She presented with a mandibular swelling that had been evolving for 6 years, with no other functional signs and no change in general condition. Exobuccal examination revealed a voluminous symphyseal swelling, covered by healthy-looking skin, with a bony consistency and forming part of the mandible. On endobuccal examination, there was a vestibular swelling extending from 36 to 45, covered by healthy-looking mucosa, with the absence of teeth 31, 32, 41, 42 and 43 and mobility of teeth 33 and 34. The hypothesis of a benign tumour of the mandible was raised. A maxillofacial CT scan revealed a heterogeneous image with local areas of hyperdensity and blowing of the external cortex. Treatment consisted of an interrupting mandibular resection via the vestibular approach, followed by transitional reconstruction using a stent graft. Histological examination of the surgical specimen revealed an ossifying fibroma. The outcome was favourable, with no recurrence after approximately 2 years.</p><p><strong>Conclusion: </strong>Treatment of ossifying fibroids can often be mutilating. It is discussed according to the clinical and radiological characteristics of the lesion.</p>","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 3","pages":"65-68"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}